MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-KR-03-0142600
Nacc Pharmaceutical Private Limited - pharma in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹64.14 Lakh
▼ 15% YoY
Net profit · FY 2025
₹1.01 Lakh
Net margin 1.6%
EBITDA · FY 2025
₹4.84 Lakh
EBITDA margin 7.5%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Employees · EPFO
6
Provident fund records
Directors on board
2
As per MCA filings
About Nacc Pharmaceutical Private Limited
Data last updated:
Nacc Pharmaceutical Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24110KA2019PTC130795. Its GSTIN is 29AAGCN8027M1ZV (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Venkataramanappa Adinarayana Sravan Kumar and Chowdappa Geetha.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at No.5 Spandana 1st Flr No.4 1st Main Rd Virupakashapura Kodgehalli Vidyaranyapur, Bangalore, Karnataka, India – 560097.
As per the financials filed for FY 2025, the company reported a revenue of ₹64.14 Lakh, a decline of 15% compared to the previous year. For the same year it recorded a net profit of ₹1.01 Lakh (net margin 1.6%) and EBITDA of ₹4.84 Lakh (EBITDA margin 7.5%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years.
The company has about 6 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: NACC Pharmaceutical.
Nacc Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0142600). For more details, the company can be reached via its website naccpharmaceutical.com.
Company details
CIN U24110KA2019PTC130795
Registration Number 130795
Incorporation Date 19 December 2019
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
MSME Classification Micro
Udyam Registration UDYAM-KR-03-0142600
Recognitions & Rankings of Nacc Pharmaceutical
Contact details
Nacc Pharmaceutical Private Limited's registered office is in Bangalore, Karnataka. Its website is naccpharmaceutical.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNo.5 Spandana 1st Flr No.4 1st Main Rd Virupakashapura Kodgehalli Vidyaranyapur, Bangalore, Karnataka, India – 560097
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Nacc Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Nacc Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Nacc Pharmaceutical operates one associated brand: NACC Pharmaceutical. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical products and services in healthcare, focusing on innovation and therapeutic solutions in India. | naccpharmaceutical.com |
Business activity
The main business activity of Nacc Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Nacc Pharmaceutical Private Limited, buy the company report.
Financials of Nacc Pharmaceutical Private Limited
FY 2023 filings availableNacc Pharmaceutical Private Limited reported revenue of ₹64.14 Lakh (down 15% YoY) for FY 2025.
Revenue · FY 2025
₹64.14 Lakh ▼ 15%
Net profit · FY 2025
₹1.01 Lakh margin 1.6%
EBITDA · FY 2025
₹4.84 Lakh margin 7.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 15%
3 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▲ 4%
3 years · compounded
▲ 7%
5 years · compounded
▲ 26%
Revenue fell 15% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 7%. EBITDA rose 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.84 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.01 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.5% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nacc Pharmaceutical Private Limited, buy the company report.
Board of directors of Nacc Pharmaceutical Private Limited
Nacc Pharmaceutical has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkataramanappa Adinarayana Sravan Kumar | Director | 19 Dec 2019 | 6 Years 10 Months | Current |
| Chowdappa Geetha | Additional Director | 11 Jan 2025 | 1 Years 9 Months | Current |
Auditor
Nacc Pharmaceutical Private Limited is audited by BHASKAR REDDY & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BHASKAR REDDY & CO | FY 2023 | 016368S |
Shareholding
The shareholding of Nacc Pharmaceutical Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Nacc Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nacc Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nacc Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Nacc Pharmaceutical Private Limited has a workforce of 6 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
Employee count
6
Active EPFO establishments
1
Employee growth
-14.29%
GST
Nacc Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAGCN8027M1ZV | Karnataka | Active | 30 Jan 2020 |
To see the full GST registrations and return filing status of Nacc Pharmaceutical Private Limited, buy the company report.
Recent activity
Nacc Pharmaceutical Private Limited has 6 board changes on record since 2019: 4 appointments and 2 cessations. The latest: Chowdappa Geetha was appointed as Additional Director on 11 Jan 2025.
Appointed
Chowdappa Geetha was appointed as Additional Director.
Ceased
Kummari Subbaiah ceased to be Director.
AGM
Nacc Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Nacc Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore.
Ceased
Nagaraja Shetty Vageesha ceased to be Director.
Appointed
Kummari Subbaiah was appointed as Director.
Appointed
Nagaraja Shetty Vageesha was appointed as Director.
Appointed
Venkataramanappa Adinarayana Sravan Kumar was appointed as Director.
Incorporation
19 Dec 2019
Nacc Pharmaceutical Private Limited was registered on 19 Dec 2019 with Roc Bangalore & aged 6 years 10 months as per MCA records.
Frequently asked questions
Nacc Pharmaceutical is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 December 2019 (7+ years old) and is registered under CIN U24110KA2019PTC130795.
Nacc Pharmaceutical has 2 current directors:
- Venkataramanappa Adinarayana Sravan Kumar - Director
- Chowdappa Geetha - Additional Director
The latest financial statements of Nacc Pharmaceutical on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Nacc Pharmaceutical is 29AAGCN8027M1ZV, registered in Karnataka.
The CIN (Corporate Identification Number) of Nacc Pharmaceutical is U24110KA2019PTC130795. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nacc Pharmaceutical was incorporated on 19 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Bangalore.
Chowdappa Geetha was appointed as Additional Director on 11 Jan 2025. Kummari Subbaiah ceased to be Director on 11 Jan 2025. Nagaraja Shetty Vageesha ceased to be Director on 10 Mar 2022. Nacc Pharmaceutical has 6 board changes on record in total.
Yes, Nacc Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0142600).
Nacc Pharmaceutical can be reached through the website naccpharmaceutical.com. Its registered office is in Bangalore, Karnataka, India.
The registered office of Nacc Pharmaceutical is at No.5 Spandana 1st Flr No.4 1st Main Rd Virupakashapura Kodgehalli Vidyaranyapur, Bangalore, Karnataka, India – 560097.